Elon Musk Backed Neuralink has secured permission from the Canadian authorities to conduct tests and trials for a device designed to give paralyzed individuals the ability to use digital devices simply by thinking. 

Objective 
The study aims to test the device for safety and initial functionality of its implant. This would be assessed after installing the device in patients suffering from Quadriplegia, a paralysis of all four limbs, to check the efficacy of the innovation.

Approval 
The trials will be hosted at Toronto Western Hospital, a unit under Canada’s University Health Network. With the approval in place, Canada becomes the first site of the US to approve such trials.  

UHN Chief Executive Officer Kevin Smith articulated pride in the hospital’s role as the “first and exclusive” Canadian site for this research, highlighting its pivotal role in advancing neurosurgical innovation, Firstpost reports. 

Problem-Solution 
Neuraklink aims to target patients suffering from Quadriplegia caused by ALS (Amyotrophic Lateral Sclerosis) or spinal cord injuries. The solution provided by the company, precisely the Brain-Computer (BC) Interface allows the patients to control devices like computers through thought alone, potentially transforming their quality of life.  

Future-ready Tech 
The company has also laid ambitious plans to further the tests and trials into conditions like blindness and enhance cognitive abilities. It is a breakthrough idea in the neurological ecosystem to enable a patient with such neurological problems to gain a chance at life again, a first-of-its-kind thing in humankind. 

Recent Success 
Neuralink reached a significant milestone by implanting its device in its first human patient, Noland Arbaugh, at the Barrow Neurological Institute in Phoenix. The success of this procedure has opened the door for additional trials and global expansion.
In September, the startup was granted the U.S. Food and Drug Administration's "breakthrough device" designation for its experimental implant designed to restore vision.